The serum protein responses to treatment with Xiaoke Pill and Glibenclamide in type 2 diabetes patients
Abstract Aim The Xiaoke Pill containing Chinese herb extracts and Glibenclamide, is used in therapy for type 2 diabetes mellitus (T2DM), and is effective in reducing the risk of hypoglycemia and improving diabetes symptoms compared with Glibenclamide. We describe a quantitative proteomics project to...
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | 論文 |
| 言語: | English |
| 出版事項: |
BMC
2017-05-01
|
| シリーズ: | Clinical Proteomics |
| 主題: | |
| オンライン･アクセス: | http://link.springer.com/article/10.1186/s12014-017-9154-0 |